Penumbra | Sustainability Performance
Develops medical technologies used in interventional procedures for neurological and vascular conditions, producing devices intended to support clinical workflows and therapeutic interventions in specialized care settings.
2004
United States
1,001 - 5,000 employees
Medical Device
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#9010
Overallⓘ#2062
in United Statesⓘ#143
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Penumbra Inc, US neurovascular/peripheral vascular medical devices, has faced multiple US FDA Form 483 observations including the historic 2020 USD 200+ million Jet 7 Reperfusion Catheter recall affecting US neurovascular customer sites, plus periodic class actions over alleged inadequate disclosure of US FDA enforcement affecting US institutional shareholders amid medical devices customer compliance.
